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Abstract
Background: Cluster headache (CH) is regarded as a chronobiological disorder. The hypothalamic biological clock
may thus be involved in the pathophysiology, but few studies have actually investigated this in CH patients. A
variable number tandem repeat (VNTR) polymorphism of the PER3 clock gene has been associated to preferred
daily rhythm (chronotype) in several studies. We aimed to study the distribution of PER3 VNTR polymorphisms and
chronotypes in a CH population.
Methods: We used blood samples from a biobank of CH patients for genetic tests, and invited all tested patients
to complete the Horne-Ostberg Morningness-eveningness Questionnaire (MEQ), the Pittsburgh sleep quality Index
(PSQI) and the Shift Work Index. Genotypes were compared to a previously tested population of 432 healthy students.
Results: One hundred forty nine patients were genotyped, and we found no difference in PER3 VNTR polymorphisms
between patients and controls. Seventy-four patients completed the MEQ (54 men, 20 women, mean age 52.3 years ±
13.4), and chronotypes were as follows: 12 % morning-, 37 % intermediate-, and 51 % evening types. Compared with a
previous Danish study of CH patients and controls, there were no difference in chronotype distribution. Sixty percent of
patients were defined as bad sleepers (PSQI >5), and 51 % of patients currently employed were shift workers.
Conclusions: No association between CH, PER3 VNTR polymorphism and chronotype was found in this study.
Keywords: Cluster headache, Chronotype, PERIOD3, Clock genes, Shift work, Horne-Ostberg Morningness eveningness
questionnaire
Background
Cluster headache (CH) is a periodic disorder, with a
striking rhythmic occurrence of headache attacks and
bouts. Up to 80 % of patients report a predictable di-
urnal rhythmicity of attacks [1], and the attacks seem
to occur most often at night between midnight and
04 a.m. [2], waking the patient from sleep. CH has
been associated with shift work and chronic insomnia
[2], and it has recently been demonstrated that CH
patients in bouts have reduced REM sleep and fewer
sleep arousals compared to controls [3]. The periodicity of
attacks and apparent sleep disturbances imply that CH is
a chronobiological disorder, and that the hypothalamic
biological clock (the suprachiasmatic nucleus, SCN) may
be involved in CH pathophysiology [4].
The SCN governs the biological rhythms of the
body, oscillating in a strong 24-h cycle caused by
transcription-translation loops of the so-called clock
genes [5]. One of the key transcriptional loops run-
ning the clock is the CLOCK:BMAL1 cycle, where
the CLOCK and BMAL1 gene proteins join to form a
complex that initiates transcription of the PER
(PER1,2 and 3) and CRY (CRY1 and 2) gene families
[6]. The protein products of these genes translocate
to the nucleus and inhibit further transcription of the
CLOCK:BMAL1 complex, thereby inhibiting their
own transcription. CK1δ/ε gene coded kinases phos-
phorylate and degrade the PER/CRY proteins, allow-
ing the cycle to start over again. The length of the* Correspondence: hkofte@gmail.com
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cycle varies between individuals and sets the period
of the biological clock.
The internal clock cycle is reset every day by sev-
eral external factors, of which light is the most im-
portant. Individual differences in the endogenous
rhythms, in addition to sensitivity to light and sleep
homeostasis, determine the biological basis to what
we in daily life recognize as individual differences in
diurnal preference (chronotype). Morning types (larks)
seem to have shorter circadian cycles than evening
types (night owls), and advanced sleep phase disorder
(ASPD) and delayed sleep phase disorder (DSPD) are
viewed as extremes in opposite ends of the con-
tinuum of diurnal preferences [7]. A variable number
tandem repeat (VNTR, Table 1) of the DNA in the
clock gene PERIOD3 (PER3, rs57875989) has been
shown to correlate with diurnal preference in humans
[8], and the short allele of the PER3 VNTR was asso-
ciated to DSPD in two studies [9, 10].
A mismatch between the internal clock cycle and ex-
ternal time cues causes circadian misalignment, which
over time may lead to various health problems [11]. Both
chronotype and clock genotype contribute to how well
individuals adapt to such misalignment [12, 13]. If clus-
ter headache is indeed a chronobiological disorder, an
important question is whether the pathology resides in
the biological clock itself, or in the adaptation between
the clock and the environment. We aimed to study the
PER3 VNTR distribution, chronotype and prevalence of
sleep disturbances in a CH population, to evaluate if a
specific genotype is associated with a higher risk of CH.
Methods
PER3 VNTR genotyping
We used blood specimens obtained from a biobank lo-
cated at St. Olavs Hospital in Trondheim. The biobank
is founded by the Norwegian Advisory Unit on Head-
aches, and contains blood samples from headache pa-
tients living in the middle and northern part of Norway.
All patients included in the biobank are consulted by a
headache specialist, validating the headache diagnosis
according to the International Classification of Headache
Disorders (ICHD, version 2 and 3-beta) [14]. In addition,
the patients must complete a form with questions re-
garding clinical characteristics, use of medication and
work status. In spring 2014, all patients registered in the
biobank with a diagnosis of CH were identified and
DNA extracted from the specimens. There was no kin-
ship between the patients. DNA samples were purified,
and polymerase chain reaction (PCR) amplification of
the PER3 polymorphism performed according to previ-
ously validated methods [9, 15]. We used forward primer
5’-CAAAATTTTATGACACTACCAGAATGGCTGAC-3’
and reverse primer 5’-AACCTTGTACTTCCACATCAG-
TGCCTGG-3’, as reported by Ebisawa et al. [9]. Gel
electrophoresis was used to differentiate the PER3
genotypes. We used information on clincial character-
istics from the biobank to compare the different
genotypes.
The PER3 genotype distribution in the CH population
was compared to that of a previously published popula-
tion of 432 healthy Norwegian students (176 males and
256 females, mean age 22 years, SD ± 2,6) [15].
Chronotyping and sleep assessment
All the genotyped patients subsequently received an
invitation by mail to participate in further studies,
and were asked to complete and return the Horne-
Ostberg Morningness-Eveningness Questionnaire (MEQ),
Pittsburgh Sleep Quality Index (PSQI), and the Standard
Shiftwork Index (SWI). All three questionnaires are vali-
dated in Norwegian translations.
Horne-Ostberg morningness-eveningness questionnaire
(MEQ)
The MEQ is one of the most widely used and best
validated tools for measuring diurnal preference [16].
It consists of 19 multiple-choice items, producing a
score ranging from 16 to 86, with high scores indicat-
ing morning preference and low scores indicating
evening preference. The initial chronotype cut-off
points were validated for a population of young stu-
dents, and as chronotype is strongly influenced by
age and social factors, validated cut-off points for a
middle-aged, non-shift working population have later
been made [17]. We had no control group of our
own for these data, but compared the results with a
recent Danish study, chronotyping 275 CH patients
and 145 controls [1]. The authors kindly provided
chronotype distribution in the Danish populations ad-
justed for age (private correspondence).
Pittsburgh sleep quality index (PSQI)
The PSQI is a validated, retrospective measure of sub-
jective sleep quality and disturbances during the last
month [18]. It consists of 19 items grouped into seven
equally weighted component scores, with higher scores
indicating poorer sleep quality. The maximum score is
21, and a score above five indicates a poor sleeper.
Table 1 Variable number tandem repeats
A variable number tandem repeat occurs in DNA when a pattern
of one or more nucleotides is repeated, and the repetitions are
directly adjacent to each other. In the human PER3 gene, the short
allele contains four tandem 54-bp repeats, and the long allele has five
such repeats. As each individual has two sets of alleles, this produces
three possible genotypes: PER3 4/4, 4/5 and 5/5.
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Standard shiftwork index (SWI)
The SWI is a standardized battery of questions devel-
oped to study the psychological and physiological impact
of shift work [19]. We used it mainly to identify shift
workers, as the small number of participants made
detailed studies on adaptation to different shifts less
reliable.
Statistical methods, power calculation and ethics
The null hypothesis was that there is no difference in
PER3 polymorphism or chronotype distribution between
CH patients and controls. We also hypothesized that in
the subgroup analysis; there would be no correlation be-
tween PER3 genotype and MEQ-score, PER3 genotype
and PSQI-score, and between the MEQ and PSQI. The
frequencies of genotypes and chronotypes were com-
pared with chi-square tests. Continuous variables were
compared between genotypes with one-way ANOVA.
The association between genotype and MEQ or PSQI
scores was tested in a multiple, linear regression model,
adjusted for age, gender and shift work. The level of sig-
nificance was set at 0.05 for all statistical tests. No a
priori power calculations were made.
The data were analyzed using the SPSS software pack-
age for Windows version 21 (SPSS Inc, Chicago, IL,
USA). The Research Ethics Committee of Northern
Norway reviewed the protocol and recommended the
study. The Norwegian Data Protection Authority ap-
proved of data registration.
Results
PER3 VNTR genotyping
Genetic analysis of PER3 VNTR was performed in 149
CH patients (109 males and 40 females, mean age
54.1 years, SD ± 14.0). Table 2 shows the distribution of
genotypes in 432 healthy controls, the total group of 149
CH patients, and in the subgroup of 74 CH patients who
were also chronotyped. When comparing the total CH
population to healthy controls, there was no difference
in PER3 VNTR polymorphism (χ2 (2) = 0.016, p = 0.992).
The genotype distribution was in Hardy-Weinberg equi-
librium, and the PER3 allele frequencies were the same
for both populations (0.67 for the 4-allele and 0.33 for
the 5-allele). Table 3 shows clinical characteristics in
the CH population, divided between the PER3 geno-
types. There were no statistically significant differ-
ences between the three genotypes with regards to
gender, age or clinical characteristics (calculations not
shown). Unfortunately, there was no information
available regarding episodic or chronic CH.
Subgroup analysis
Eighty of the 149 CH patients responded to our invita-
tion and returned the questionnaires. Of these, 74 com-
pleted both the MEQ and PSQI forms and were
included in subgroup analysis (54 men and 20 women,
mean age 52.3 years ± 13.4). The mean MEQ was 51.4 ±
10.5, and based on individual values we found the fol-
lowing chronotype distribution: 38 (51 %) evening type,
27 (37 %) intermediate type, and nine (12 %) morning
type. Table 4 shows chronotype distribution in the
present CH patient subgroup, compared to the previ-
ously chronotyped CH population and healthy controls
from Denmark [1]. There was no difference in chrono-
type distribution between the groups (p = 0.595).
The mean PSQI was 8.4 ± 4.6, and 44 of the re-
sponders (60 %) were defined as bad sleepers (PSQI > 5).
Table 2 shows mean MEQ and PSQI in each PER3 geno-
type. Seventy-six patients answered questions about shift
work. Of the 49 patients currently employed, 25 (51 %)
were shift workers and another nine (18 %) had previ-
ously worked shifts. Of the total group of 76 responders,
40 (52 %) were current or previous shift workers.
We found no association between PER3 VNTR poly-
morphism and chronotype (χ2(4) = 4.42, p = 0.352). The
multiple regression analysis adjusted for age, gender and
shift work, showed no association between PER3 poly-
morphism and MEQ score. The PSQI scores seemed to
decline from the PER3 4/4 to the PER3 5/5 genotype,
but this was not statistically significant. Likewise, there
was no association between MEQ and PSQI scores.
Discussion
We found no association between PER3 VNTR poly-
morphism and CH in his study. There seem to be a high
proportion of evening types in this Norwegian CH
Table 2 PER3 genotype distribution in 432 healthy controls and the total group of 149 CH patients, and PER3 genotype distribution,
MEQ and PSQI scores in the subgroup of 74 patients who completed both questionnaires
PER3 genotype Controls CH patients CH patients MEQa PSQIa
Subgroupa (Mean ± SD) (Mean ± SD)
4/4 192 (44.5 %) 67 (45.0 %) 32 (43.2 %) 52.5 ± 9.8 9.1 ± 4.8
4/5 191 (44.0 %) 65 (43.5 %) 32 (43.2 %) 51.0 ± 11.7 8.1 ± 4.6
5/5 49 (11.5 %) 17 (11.5 %) 10 (13.5 %) 49.5 ± 8.9 6.5 ± 4.1
Total/mean 432 149 74 51.4 ± 10.5 8.4 ± 4.6
aPatients included in MEQ and PSQI analysis, n = 74
Ofte et al. The Journal of Headache and Pain  (2016) 17:18 Page 3 of 6
cohort, but we found no statistically significant differ-
ence in chronotype distribution when compared to a
previously published Danish CH population and their
healthy controls. The lack of association may be due to
small sample size, or to the fact that MEQ is heavily in-
fluenced by age and social factors such as work sched-
ules [20]. Thus, the activities of daily life may mask a
true difference in clock period between individuals.
To the best of our knowledge, only one clock gene
mutation has previously been investigated in a CH
population. A single nucleotide polymorphism (SNP)
in the downstream region of the Clock gene (T3111C)
was studied in three separate Italian studies [21–23],
all of which found no difference in genotype distribu-
tion between CH patients and healthy controls. The
complexity of the biological clock was demonstrated
in a genome-wide study from 2009, in which screen-
ing of small interfering RNAs showed that more than
200 genes were involved in clock functioning, regulat-
ing amplitude and period [24]. This illustrates that
further research is needed to determine the role of
clock involvement in CH.
Sixty percent of the CH patients in our study were de-
fined as bad sleepers, and sleep disturbances seem to be
a consistent finding in studies of CH [1, 2, 4]. A mean
PSQI of 8.4 is high even when compared to other head-
ache populations. In a study from 2009, the authors
found a mean PSQI of 5.9 ± 3.0 in migraine patients who
suffered ≥ 8 migraine days a month [25]. Sleep is one of
the most important attack triggers in CH [2], but insom-
nia is not merely a result of nocturnal headache disrupt-
ing sleep, as sleep quality remains poorer compared to
controls as long as one year after last headache attack
[1]. Recent studies have shown that sleep homeostasis
and the circadian oscillations of the SCN are more inter-
connected at the molecular level than previously thought
[26], and the sleep disturbances in CH populations could
therefore be a direct result of clock involvement in CH
pathophysiology. The relationship between CH and sleep
is further underlined by the association between CH and
a missense SNP in the hypocretin receptor-2 gene
(HRCTR2) reported in several studies, although a recent
meta-analysis cast doubt on this finding [27].
Fifty-one percent of the patients in this cohort cur-
rently employed were shift workers. For comparison,
about 33 % of the general workforce in Norway work
outside regular office hours (https://www.ssb.no/en/
arbeid-og-lonn/statistikker/yrkeaku/aar/2012-04-26#con-
tent). Adaptation to shift work is influenced by both
chronotype and clock genotype [12]. Night workers are
Table 3 Clinical characteristics of 149 genotyped CH patients, divided between the three PER3 genotypes 4/4, 4/5 and 5/5
PER3 genotype 4/4 4/5 5/5
Gender (M/F) 50/17 50/15 9/8
Age at inclusion (years) 52.8, SD ± 14.5 55.6, SD ± 13.5 53.9, SD ± 14.5
Comorbid migraine without aura (N) 1 (1.5 %) 0 3 (17.6 %)
Comorbid migraine with aura (N) 5 (7.5 %) 5 (7.7 %) 1 (5.9 %)
Comorbid tension type headache (N) 1 (1.5 %) 1 (1.5 %) 0
Age at onset (years) 28.9, SD ± 13.1 31.0, SD ± 14.5 31.1, SD ± 13.9
Headache intensity: strong (N) 9 (13.4 %) 4 (6.2 %) 1 (11.8 %)
Headache intensity: extra strong (N) 37 (55.2 %) 39 (60 %) 10 (58.8 %)
Attack duration (minutes) 13.9, SD ± 8.5 13.9, SD ± 9.1 19.0, SD ±11.0
Number of attacks per month 5.7, SD ± 8.2 4.0, SD ± 7.6 4.7, SD ± 11.2
Number of attacks per day 3.3, SD ± 2.2 3.6, SD ± 3.2 3.0, SD ± 2.1
Total number of headache days in the last 3 months 12.3, SD ± 12.1 12.3, SD ± 11.0 17.1, SD ± 16.6
Total number of patients N = 67 N = 65 N = 17
Table 4 Chronotype distribution in the present cohort of 74 CH patients in percent, as well as chronotypes described in a Danish
CH population and their healthy controls
Norwegian CH patients (%) Danish CH patients (%) Danish controls (%)
Evening type (MEQ scores 16–52) 51 45 42
Neither type (MEQ scores 53–64) 37 43 41
Morning type (MEQ scores 65–86) 12 12 17
Total number (N) 74 275 145
MEQ score cut-offs from Taillard [17] are used
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more probable to be definite evening types compared to
daytime workers [20], and it seems that morning types
adapt better to daytime work than evening types. The
CH patients in our study are mostly evening types, and
we do not know if their evening preference is a result of
the shift work or if they choose to work shifts because it
suits them better. Theoretically, shift work may result in
a circadian misalignment that could trigger CH in pre-
disposed individuals. Further research is needed on the
association between CH and shift work occupation.
Strengths and limitations
On the strong side, headache specialists had validated
the CH diagnosis of all the participants prior to in-
clusion in the headache biobank. CH patients and
controls were mainly ethnic Norwegians, thus suitable
for genetic comparison. The controls were signifi-
cantly younger than the CH patients, and there were
more men in the patient group, but as genotype is a
constant trait, and not associated with reduced life-
time expectancy or to a specific gender, this is irrele-
vant for our analysis. We used previously validated genetic
tests and test tools, as well as validated Norwegian transla-
tions of the questionnaires.
The greatest limitation to our study concerns the issue
of statistical power. Power calculations in genetic associ-
ation studies rely heavily on the effect size that the can-
didate gene exerts on the disease or trait studied. This
effect is unknown in our case, and could only be based
on assumptions. It is generally accepted that common
complex diseases are unlikely to be caused by a single
locus of large effect, and that genotypic relative risks are
likely to be in the range of 1–1.5 [28]. CH is a rare dis-
ease, but it is most probably of a complex genetic origin.
The limited access to patients makes large genetic stud-
ies on CH difficult to conduct, and our study is probably
underpowered. This warrants caution in interpreting the
results. However, genetic studies are important to de-
velop a better understanding of the pathophysiology
even in rare headache disorders. Despite its small sample
size, we believe that this study adds to the knowledge of
CH pathophysiology.
Conclusion
This study shows that CH patients have the same distri-
bution of PER3 VNTR polymorphism and chronotype as
healthy controls. There is a high frequency of sleep dis-
turbances and shift work occupation in the CH popula-
tion. Further research on the association between CH,
clock genes and their regulators are needed.
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